Related Experiment Video
Updated: Jul 6, 2025

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Gastrodin: a comprehensive pharmacological review
Yulin Wang1,2, Mengting Bai1,2, Xian Wang1,2
1State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Gastrodin (GAS), derived from Tianma, shows significant therapeutic potential for neurological, cardiovascular, and liver diseases. Microbial synthesis and derivatives offer promising avenues for its development and application.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Traditional Chinese Medicine
Background:
- Tianma (Gastrodia elata Blume) is a traditional Chinese medicine.
- Gastrodin (GAS) is the primary active compound in Tianma.
- GAS exhibits notable pharmacological activities.
Purpose of the Study:
- To review the extraction, synthesis, pharmacological effects, and derivatives of Gastrodin (GAS).
- To explore future development opportunities for GAS.
- To consolidate current research on GAS for therapeutic applications.
Main Methods:
- Literature review of studies on Gastrodin (GAS).
- Analysis of extraction and synthesis methods, including microbial production.
- Examination of pharmacological data and derivative research.
Main Results:
- Microbial synthesis presents a promising production method for GAS.
- GAS demonstrates efficacy in treating neurological, cardiovascular, endocrine, and liver diseases.
- Key pharmacological effects include anti-inflammatory, antioxidant, neuroprotective, and analgesic properties, mediated by pathways like Nrf2, NF-κB, PI3K/AKT, and AMPK.
- GAS derivatives and GAS-PU biomaterials indicate expanded application potential.
Conclusions:
- Gastrodin (GAS) possesses broad therapeutic potential across multiple disease areas.
- Further research into GAS derivatives and novel applications is warranted.
- GAS holds significant value for the development of new treatments.
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...

